Literature DB >> 17873576

Molecular basis of atopic dermatitis.

Sonja Bonness1, Thomas Bieber.   

Abstract

PURPOSE OF REVIEW: Atopic dermatitis is a common chronic inflammatory skin disease and there are numerous publications on this topic. This review will focus on developments in understanding the molecular basis of atopic dermatitis while considering the genetic background, skin barrier impairment, immune system deviation and microbial superinfections. RECENT
FINDINGS: Atopic dermatitis is a complex genetic disease in which gene-gene and gene-environment interactions play a key role. Surprisingly some genetic regions of interest were found to be overlapping with loci identified to play a role in another very common inflammatory skin disease, psoriasis, while no overlap has so far been observed with asthma. Impairment of the skin barrier followed by antigens trespassing seems to play an important role, favouring sensitization via transepidermal penetration which is the focus of current investigations. Superinfections by pathogens such as Staphylococcus aureus due to a weak innate defence seem to be significant in atopic dermatitis as they elicit a strong inflammatory response.
SUMMARY: Atopic dermatitis is a chronic inflammatory skin disease with a high incidence in school children and adults. Disease pathogenesis is complex and the background is multifactorial, making the underlying predispositions elusive. Understanding new pathogenic pathways may lead to the development of new drugs with enhanced benefit for the patient.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17873576     DOI: 10.1097/ACI.0b013e3282a643c3

Source DB:  PubMed          Journal:  Curr Opin Allergy Clin Immunol        ISSN: 1473-6322


  19 in total

1.  A (S)-(+)-decursin derivative, (S)-(+)-3-(3,4-dihydroxy-phenyl)-acrylic acid 2,2-dimethyl-8-oxo-3,4-dihydro-2H,8H-pyrano[3,2-g]-chromen-3-yl-ester, attenuates the development of atopic dermatitis-like lesions in NC/Nga mice.

Authors:  In Sik Kim; Dong-Hee Kim; Chi-Young Yun; Ji-Sook Lee
Journal:  Mol Biol Rep       Date:  2013-01-05       Impact factor: 2.316

2.  IL-33: a novel danger signal system in atopic dermatitis.

Authors:  Ferda Cevikbas; Martin Steinhoff
Journal:  J Invest Dermatol       Date:  2012-05       Impact factor: 8.551

3.  Down-regulation of IL-6, IL-8, TNF-α and IL-1β by glucosamine in HaCaT cells, but not in the presence of TNF-α

Authors:  Kun Park; Ji-Hye Lee; Ho-Chan Cho; Sun-Young Cho; Jae-We Cho
Journal:  Oncol Lett       Date:  2010-03-01       Impact factor: 2.967

Review 4.  The development of allergic inflammation.

Authors:  Stephen J Galli; Mindy Tsai; Adrian M Piliponsky
Journal:  Nature       Date:  2008-07-24       Impact factor: 49.962

Review 5.  Immunologic, microbial, and epithelial interactions in atopic dermatitis.

Authors:  Patrick M Brunner; Donald Y M Leung; Emma Guttman-Yassky
Journal:  Ann Allergy Asthma Immunol       Date:  2017-11-07       Impact factor: 6.347

6.  Role of the complement anaphylatoxin C5a-receptor pathway in atopic dermatitis in mice.

Authors:  Lin Dang; Lei He; Yan Wang; Jikui Xiong; Bingxue Bai; Yuzhen Li
Journal:  Mol Med Rep       Date:  2015-02-04       Impact factor: 2.952

7.  Effects of Ixeris dentata water extract and caffeic acid on allergic inflammation in vivo and in vitro.

Authors:  Yong-Deok Jeon; Ji-Ye Kee; Dae-Seung Kim; Yo-Han Han; Sung-Hoon Kim; Su-Jin Kim; Jae-Young Um; Seung-Heon Hong
Journal:  BMC Complement Altern Med       Date:  2015-06-24       Impact factor: 3.659

8.  Allergen-Specific Immunotherapy with Monomeric Allergoid in a Mouse Model of Atopic Dermatitis.

Authors:  Nadezda Shershakova; Elena Bashkatova; Alexander Babakhin; Sergey Andreev; Alexandra Nikonova; Igor Shilovsky; Oleg Kamyshnikov; Andrey Buzuk; Olga Elisyutina; Elena Fedenko; Musa Khaitov
Journal:  PLoS One       Date:  2015-08-14       Impact factor: 3.240

Review 9.  Influences of Environmental Chemicals on Atopic Dermatitis.

Authors:  Kwangmi Kim
Journal:  Toxicol Res       Date:  2015-06

10.  Neurotensin and CRH interactions augment human mast cell activation.

Authors:  Konstantinos-Dionysios Alysandratos; Shahrzad Asadi; Asimenia Angelidou; Bodi Zhang; Nikolaos Sismanopoulos; Hailing Yang; Agatha Critchfield; Theoharis C Theoharides
Journal:  PLoS One       Date:  2012-11-14       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.